Company Filing History:
Years Active: 2003
Title: Sarkis Serge Shahinian: Innovator in Antifungal Research
Introduction
Sarkis Serge Shahinian is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of antifungal research, particularly through his innovative patent related to Candida albicans.
Latest Patents
Shahinian holds a patent titled "Candida albicans KRE9 and uses thereof." This invention pertains to an isolated DNA that codes for a gene essential for cell wall glucan synthesis, referred to as CaKRE9. The patent outlines the sequence of the DNA and describes antifungal in vitro and in vivo screening assays for identifying compounds that inhibit the synthesis, assembly, and regulation of β1,6-glucan. Additionally, it discloses an in vitro method for diagnosing diseases caused by fungal infections in patients.
Career Highlights
Sarkis Serge Shahinian is affiliated with McGill University, where he continues to advance his research in the field of microbiology and antifungal treatments. His work has implications for improving the diagnosis and treatment of fungal infections, which can be critical in clinical settings.
Collaborations
Shahinian has collaborated with notable colleagues, including Howard Bussey and Marc Lussier, to further his research endeavors. Their combined expertise contributes to the advancement of knowledge in the field of antifungal therapies.
Conclusion
Sarkis Serge Shahinian's innovative work in antifungal research exemplifies the importance of scientific inquiry in addressing health challenges. His contributions through patents and collaborations continue to pave the way for advancements in medical diagnostics and treatments.